VACDIVA – A safe DIVA vaccine for African Swine Fever control and eradication

African swine fever (ASF) is a devastating infectious disease in pigs – usually deadly. No vaccine exists to combat this virus. The European Union has laid down prevention and control measures to be applied where African swine fever is suspected or confirmed, either in holdings or in wild boars.
The EU-funded VACDIVA project aims to provide three safe and effective pilot vaccines for wild boar and domestic pigs that is ready for registration. It also validates tests and developes cost-benefit and -effective surveillance and control-vaccination strategies.

Details

Status:

Research Focus:

  • Medicine and Health

Project Coordination:

Universidad Complutense De Madrid
(UCM)

Other Partners:

Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain Gold Standard Diagnostics Madrid, Spain HORIZCIENCE SL, Spain Allatorvostudomanyi Kutatointezet, Hungary Nemzeti Elelmiszerlanc-Biztonsagi Hivatal, Hungary China Animal Health And Epidemiology Center, China Institute Of Animal Science (Ias), Chinese Academy Of Agricultural Sciences (Caas), China European Coordination Via Campesina, Belgium Faculdade De Medicina Veterinaria, Portugal Fgi Federal Centre For Animal Health, Russia Intervet International Bv, Netherlands Stichting Wageningen Research, Netherlands Istituto Zooprofilattico Sperimentale Dell'umbria E Delle Marche, Italy Istituto Zooprofilattico Sperimentale Della Sardegna G. Pegreffi, Italy Nacionalinis Maisto Ir Veterinarijos Rizikos Vertinimo Institutas, Lithuania Partikas Drosibas, Dzivnieku Veselibas Un Vides Zinatniskais Institutsbior, Latvia Riigi Laboriuuringute Ja Riskihindamise Keskus, Estonia Statni Veterinarni Ustav Jihlava, Czechia

Countries:

Germany (Bavaria), Kenya

Funding Agency:

European Union (EU)

Funding Type:

H2020

Duration:

01/10/2019
31/12/2024

Budget:

9168652 EUR

URL: